01—Abstract
Summary
Summary of the 8-K filed July 22, 2025. Cited figures are marked; the original filing is the authoritative source.
The Coca-Cola Company (KO) reported second quarter 2025 results on July 22, 2025, showing mixed headline numbers that are heavily distorted by one-time items.
Net revenues grew 1% to $12.5 billiona and organic revenues (non-GAAP) grew 5%, driven by 6% price/mix, while unit case volume declined 1% and concentrate sales fell 1%. Reported operating income surged 63% to $4.3 billion and reported diluted EPS rose 58% to $0.88, but these gains primarily reflect the prior-year $1.37 billion fairlife contingent consideration remeasurement charge. On a comparable basis, currency-neutral operating income grew 15%, comparable operating margin expanded to 34.7% from 32.8%, and comparable EPS grew 4% to $0.87, which included an 11-point currency headwind on reported EPS and a 5-point headwind on comparable EPS.
Cash flow was the most notable weak spot. Operating cash flow was negative $1.4 billionb for the first six months, reflecting the $6.1 billion fairlife contingent consideration payment made in March 2025. Free cash flow was negative $2.1 billion, but excluding that payment it was $3.9 billion.
Management kept its underlying 2025 guidance largely intact, including 5% to 6% organic revenue growth and projected free cash flow excluding the fairlife payment of about $9.5 billionc. It made several updates, however: comparable currency-neutral EPS growth of about 8% (updated), comparable EPS growth of about 3% versus $2.88 in 2024 (updated), and an approximate 5% currency headwind to comparable EPS growth. Management also introduced a Q3 2025 outlook calling for a 5% to 6% currency headwind to comparable EPS growth.
For investors, the key takeaways are solid underlying operating momentum and pricing power, offset by volume softness, a meaningful currency drag, and a temporarily depressed cash flow figure that the company expects to normalize over the year. The reported and comparable numbers diverge sharply, so investors should focus on the non-GAAP comparable and currency-neutral measures to gauge underlying trends.
02—Key points
Key Highlights
- Net revenues grew 1% to $12.5 billion; organic revenues (non-GAAP) grew 5%, driven by 6% price/mix, while unit case volume declined 1%.
- Reported operating income rose 63% to $4.28 billion and reported operating margin reached 34.1% versus 21.3%, largely due to lapping a $1.37 billion prior-year fairlife contingent consideration charge.
- Comparable currency-neutral operating income (non-GAAP) grew 15%; comparable operating margin expanded to 34.7% from 32.8%, supported by organic growth, timing of marketing investments and cost management.
- Reported diluted EPS grew 58% to $0.88; comparable EPS (non-GAAP) grew 4% to $0.87, absorbing a 5-point currency headwind.
- Operating cash flow was negative $1.4 billion for the first half, reflecting a $6.1 billion fairlife contingent consideration payment; free cash flow excluding that payment was $3.9 billion.
- Full-year 2025 guidance reaffirmed for organic revenue growth (5% to 6%) and projected free cash flow excluding the fairlife payment (~$9.5 billion), while comparable currency-neutral EPS growth (~8%) and comparable EPS growth (~3% vs. $2.88) were updated, reflecting currency headwinds.
- Regional performance was mixed: North America and Europe, Middle East & Africa grew organic revenue, Latin America's comparable currency-neutral operating income rose 38%, and Bottling Investments declined sharply due to refranchising and India volume losses.
03—Questions
Frequently Asked Questions
Why did reported operating income and EPS jump so much if underlying growth was modest?
The prior-year second quarter included a $1.337 billion charge tied to remeasuring the fairlife contingent consideration liability to fair value. Lapping that charge drives most of the 63% reported operating income increase and 58% reported EPS increase. On a comparable basis, operating income grew 9% in reported-currency terms and 15% on a currency-neutral basis, and comparable EPS grew 4%.
Why is free cash flow negative, and is that a concern?
Operating cash flow for the first six months was negative $1.4 billion because of the $6.1 billion fairlife contingent consideration payment made in March 2025. Excluding that payment, free cash flow was $3.9 billion, up from $3.3 billion a year earlier. The payment was a one-time settlement of an obligation from the 2020 fairlife acquisition, and management still projects roughly $9.5 billion of free cash flow excluding it for full-year 2025.
What changed in the full-year 2025 guidance?
Organic revenue growth (5% to 6%), the underlying effective tax rate (20.8%), and the free cash flow projection ($9.5 billion excluding the fairlife payment) were unchanged. Comparable currency-neutral EPS growth was updated to about 8%, comparable EPS growth to about 3% versus $2.88 in 2024, and the company now expects about a 5% currency headwind to comparable EPS growth, plus about a 1% headwind from acquisitions and divestitures. Comparable net revenues are now expected to face a 1% to 2% currency headwind.
How is volume performing, and what is driving pricing?
Unit case volume declined 1% in the quarter, with growth in Central Asia, Argentina and China offset by declines in Mexico, India and Thailand. Price/mix grew 6%, driven by pricing actions and favorable mix, and the company gained value share in total nonalcoholic ready-to-drink beverages. Coca-Cola Zero Sugar grew 14% and Diet Coke posted its fourth consecutive quarter of North American volume growth, while Trademark Coca-Cola declined 1%.
What is the outlook for the third quarter of 2025?
Management expects comparable net revenues to include an approximate 1% currency headwind and comparable EPS growth to absorb a 5% to 6% currency headwind, based on current rates including hedges. Because currency is a large drag, investors should evaluate the comparable currency-neutral results to see the underlying trend.
04—Continue